about
Urinary D-arabinitol/L-arabinitol levels in infants undergoing long-term antibiotic therapyQuadriceps femoris spasticity in children with cerebral palsy: measurement with the pendulum test and relationship with gait abnormalities.Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI).Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study.Postural sway in children and young adults, survivors of CNS tumours.Determination of urinary D-/L-arabinitol ratios as a biomarker for invasive candidiasis in children with cardiac diseases.Quantifying repeatability of the Wartenberg pendulum test parameters in children with spasticity.Posture control development in children aged 2-7 years old, based on the changes of repeatability of the stability indices.Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension.Congenital brain tumors in a series of 56 patients.Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre.Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex.Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex.Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.Invariant sway properties in children.Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.The frequency of NBN molecular variants in pediatric astrocytic tumors.Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma.Segmental movements of the spine during treadmill walking with normal speedThe IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infectionIgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-alpha therapyMagnesium status in children and adolescents with coeliac disease without malabsorption symptomsCarrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignanciesPersistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAgFunctional status of children after treatment for a malignant tumour of the CNS: a preliminary reportInfluence of the structural deformity of the spine on the gait pathology in scoliotic patientsSensitivity analysis of the estimated muscle forces during gait with respect to the musculoskeletal model parameters and dynamic simulation techniques
P50
Q34073552-B9DB2639-CFE4-4588-9BD4-FD310B789CC2Q34778590-E38F1AE0-E441-4053-BB66-A405F07F1E08Q39036969-591A40AC-CE3E-4805-B06F-CAE9C180FC20Q41053811-6C26F642-D6C1-4464-9442-4EAC035B9D1EQ41936773-C875E36D-4E87-4D54-BE83-C87713A662D8Q42596163-0D4F11AA-EEC5-4E6E-980C-501681232175Q42931905-6E5FF7E8-30DD-4843-AC9D-7D7AF6381721Q44378319-5D1EA4D8-992E-4821-B337-2D91838312FBQ45054672-BECF3BAA-E968-4B02-B93E-94B6F748F9DDQ46769411-21230AD1-6FAE-4259-B970-2C2C561F28A8Q47683970-1EBB5B7D-51B3-4C5A-A206-EFFD9366FDE9Q47996719-08B8EF4A-531B-4E9B-8F3B-F289AE3E845DQ51700459-C1DAF86E-844F-40F0-9FDF-EF80C94CD08BQ51734905-0A9980FE-36CD-4FAB-8A15-ECDC71D9D8A9Q51802737-F0ED301D-E03C-4270-85F5-2CD8AEDCE513Q52004120-D203F00B-EC36-4115-BC71-6B7F863090DCQ52141913-C08CB7FA-257F-47FD-A7FB-2CBFE4023CC4Q53360422-D2FC4271-2C64-48BF-810E-1A2DC60E2AD4Q53381775-E9393D05-806A-4C8C-8867-3A48FCD9DA58Q54496863-1CEB4CBA-15DB-4637-B85C-BE69C2B2B0B8Q64915467-DDFCCBBC-FF59-433C-9EAD-D9DDF0A1E93BQ73083543-9F1AB7C1-3DA4-4BB1-82ED-3CF323F0F57FQ73389490-BD8EB8A4-99A4-4230-B01A-E6C14AEBFC97Q73849523-8A7DFA19-51A3-4FB7-948A-53F07DE65BA9Q80592232-3F8B7B0F-D1C8-488F-B56B-2A37B1A0D506Q81190944-C79EE34B-5BF8-44E7-A174-258920A3AB21Q81513602-0F3B1DC9-6A04-4937-8D4E-BD88400200DEQ82204921-C3A6C011-6BB5-454A-AA8E-362D1BCE60D0Q85054133-B255A7FB-0479-43E8-A8EB-298F5AEFBF5BQ90884597-CD170577-D657-40EB-AD1A-3E0359D06762
P50
description
Polish researcher
@en
Pools onderzoekster
@nl
cercetătoare poloneză
@ro
chercheuse polonaise
@fr
investigadora polaca
@es
investigadora polaca
@gl
investigadora polonesa
@ca
polnische Forscherin
@de
polska naukowiec
@pl
ricercatora polacca
@it
name
Malgorzata Syczewska
@es
Małgorzata Syczewska
@ast
Małgorzata Syczewska
@ca
Małgorzata Syczewska
@cs
Małgorzata Syczewska
@de
Małgorzata Syczewska
@en
Małgorzata Syczewska
@fr
Małgorzata Syczewska
@ga
Małgorzata Syczewska
@gl
Małgorzata Syczewska
@hr
type
label
Malgorzata Syczewska
@es
Małgorzata Syczewska
@ast
Małgorzata Syczewska
@ca
Małgorzata Syczewska
@cs
Małgorzata Syczewska
@de
Małgorzata Syczewska
@en
Małgorzata Syczewska
@fr
Małgorzata Syczewska
@ga
Małgorzata Syczewska
@gl
Małgorzata Syczewska
@hr
altLabel
Malgorzata Syczewska
@en
Małgorzata Joanna Syczewska
@pl
prefLabel
Malgorzata Syczewska
@es
Małgorzata Syczewska
@ast
Małgorzata Syczewska
@ca
Małgorzata Syczewska
@cs
Małgorzata Syczewska
@de
Małgorzata Syczewska
@en
Małgorzata Syczewska
@fr
Małgorzata Syczewska
@ga
Małgorzata Syczewska
@gl
Małgorzata Syczewska
@hr
P214
P1153
57189762650
P1412
P1559
Małgorzata Syczewska
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-8872-6476
P735
P7859
viaf-311300216